This Article Full Text Full Text (PDF) CME: Take the course for this article: Intravascular Lymphoma: The Oncologist's "Great Imitator" eLetters: Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zuckerman, D. Articles by Hochberg, E. Search for Related Content PubMed PubMed Citation Articles by Zuckerman, D. Articles by Hochberg, E.

Lymphoma Series: Variants of Large-Cell Lymphoma

Intravascular Lymphoma: The Oncologist’s "Great Imitator"

Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA

Dan Zuckerman, M.D., Center for Hematology, 55 Fruit Street, Yawkey Building, 7E-7700, Boston, Massachusetts 02114, USA. Telephone: 617-724-4000; Fax: 617-724-1135; e-mail: dszuckerman{at}partners.org

Intravascular lymphoma (IVL) is a rare subtype of extranodal diffuse large B-cell lymphoma with a distinct presentation. Anatomically the disease is characterized by the proliferation of clonal lymphocytes within small vessels with relative sparing of the surrounding tissue. The clinical symptoms of the disease are dependent on the specific organ involvement, which most often includes the central nervous system and skin. Because of the various modes of presentation and the rarity of IVL, the diagnosis is often made postmortem. The diagnosis is almost exclusively made by surgical biopsy of a suspected site of involvement. Advances in imaging and immunohistochemistry have led to increasing antemortem diagnosis of this lymphoma. Although some patients with this disease may be curable with aggressive therapy, further research into novel treatment strategies is needed to improve outcome. Some potential insights into future therapies may be drawn from the small amount of basic science literature relevant to this entity. This review provides a concise, up-to-date summary of IVL.

This article has been cited by other articles:

				D. Sanchez-Cano, J. Callejas-Rubio, A. Vilanova-Mateu, M. Gomez-Morales, and N. Ortego-Centeno Intravascular lymphoma in a patient with systemic lupus erythematosus: a case report Lupus, July 1, 2007; 16(7): 525 - 528. [Abstract] [PDF]

				M. Martusewicz-Boros, E. Wiatr, E. Radzikowska, K. Roszkowski-Sliz, and R. Langfort Pulmonary Intravascular Large B-Cell Lymphoma As a Cause of Severe Hypoxemia J. Clin. Oncol., May 20, 2007; 25(15): 2137 - 2139. [Full Text] [PDF]

				T. Holmoy, P. H. Nakstad, H. L. Fredo, and T. Kumar Intravascular Large B-Cell Lymphoma Presenting as Cerebellar and Cerebral Infarction Arch Neurol, May 1, 2007; 64(5): 754 - 755. [Full Text] [PDF]